Servier’s Strategic Presence at BIO 2025
Discover Servier
Stefan Gross, Head of Biochemistry at Servier: Driving Innovation in Drug Discovery
Servier to Acquire Exclusive Worldwide Rights of BioNova’s BN104, a potential best-in-class menin inhibitor